NeuroTherm Buy Boosts St. Jude’s Pain Business
This article was originally published in Start Up
Executive Summary
NeuroTherm makes devices for radiofrequency ablation of nerves in painful facet joints in the neck or back to treat chronic pain. Although it markets neurostimulators, St. Jude currently does not sell any devices in the radio-frequency ablation segment of the pain-therapy market.
You may also be interested in...
St. Jude Medical Receives CE Mark For Prodigy Neurostimulation System
In March, St. Jude Medica received CE mark for its Prodigy Chronic Pain System with Burst Technology. According to the company, Prodigy is the only spinal cord stimulation device on the market that offers both tonic and burst stimulation to patients suffering from chronic pain.
Warning Letter Roundup & Recap – 26 January 2021
No device-related warning letters were released by the US FDA the week of 26 January.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: